2011
DOI: 10.1002/14651858.cd003510.pub3
|View full text |Cite
|
Sign up to set email alerts
|

Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
168
1
3

Year Published

2012
2012
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 231 publications
(176 citation statements)
references
References 90 publications
4
168
1
3
Order By: Relevance
“…6,7 Thus, the need for ART is lifelong and the cost is substantial 8,9 and may be difficult to sustain economically. 10 Although ART is highly efficacious in preventing transmission in the setting of mother to child transmission, 11 in sexual transmission through the treatment of infected partners in serodiscordant relationships, 12 through pre-exposure, 4,13,14 or post-exposure prophylaxis 15 scale-up difficulties and costs may make widespread implementation challenging. Furthermore, adherence is critical to the efficacy of biomedical preventive interventions but has been varied across study populations.…”
Section: Introductionmentioning
confidence: 99%
“…6,7 Thus, the need for ART is lifelong and the cost is substantial 8,9 and may be difficult to sustain economically. 10 Although ART is highly efficacious in preventing transmission in the setting of mother to child transmission, 11 in sexual transmission through the treatment of infected partners in serodiscordant relationships, 12 through pre-exposure, 4,13,14 or post-exposure prophylaxis 15 scale-up difficulties and costs may make widespread implementation challenging. Furthermore, adherence is critical to the efficacy of biomedical preventive interventions but has been varied across study populations.…”
Section: Introductionmentioning
confidence: 99%
“…1 In wealthy countries, transmission rates are below 2%. 2,3 In South Africa, the revised clinical guidelines introduced in 2010 included starting dual zidovudine/nevirapine prophylaxis commencing from 14 weeks' gestation or lifelong antiretroviral treatment (ART) for pregnant women with World Health Organization stage III or IV HIV disease and/or CD4 cell counts below 350 cells/µl. 4 However, improving South African PMTCT outcomes has been challenging owing to inadequate coverage and sub-optimal implementation of PMTCT programmes.…”
mentioning
confidence: 99%
“…Vertical transmission is highest in primary and secondary syphilis, continuing throughout pregnancy while the severity of outcomes decreases 7 . Adverse outcomes can include stillbirth or miscarriage, perinatal death, prematurity, low birthweight, and a series of early congenital manifestations (e.g.…”
Section: Resultsmentioning
confidence: 99%
“…The most important intervention to reduce perinatal HIV transmission is antiretroviral therapy for the mother 7 . It has been well established that combination therapy (rather than monotherapy) is the most effective method for reducing maternal viral load, the most important predictor of perinatal transmission 8 .…”
Section: Management During Pregnancymentioning
confidence: 99%